Medication-related osteonecrosis of the jaw; what should we do as prosthodontists?

J Prosthodont Res. 2016 Oct;60(4):229-230. doi: 10.1016/j.jpor.2016.01.004. Epub 2016 Feb 10.

¹ Department of Applied Prosthodontics, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki-city, Nagasaki 852-8588, Japan. Electronic address: kuroshima@nagasaki-u.ac.jp.
² Division of Bioprosthodontics, Niigata University Graduate School of Medical and Dental Sciences, 2-5274 Gakkocho-dori, Chuo-ku, Niigata 951-8514, Japan.
³ Section of Fixed Partial Prosthodontics, Department of Oral Rehabilitation, Fukuoka Dental College, 15-1 Tamura 2-Chome, Sawara-ku, Fukuoka 814-0193, Japan.
⁴ Section of Implant and Rehabilitative Dentistry, Division of Oral Rehabilitation, Faculty of Dental Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
⁵ Department of Applied Prosthodontics, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki-city, Nagasaki 852-8588, Japan.

No abstract available

Keywords: Bisphosphonate; Denosumab; Medication-related osteonecrosis of the jaw; Prosthodontic treatment; TRAP-positive mononuclear cells.

Publication types